Bronchopulmonary dysplasia (BPD) is a common consequence of lifesaving interventions for infants born with immature lungs. Resident tissue myeloid cells regulate lung pathology, but their role in BPD is poorly understood. To determine the role of lung interstitial myeloid cells in neonatal responses to lung injury, we exposed newborn mice to hyperoxia, a neonatal mouse lung injury model with features of human BPD. In newborn mice raised in normoxia, we identified a CD45 1 F4/ 80 1 CD11b
1, Ly6G lo-int CD71 1 population of cells in lungs of neonatal mice present in significantly greater percentages than in adult mice. In response to hyperoxia, surface marker and gene expression in whole lung macrophages/monocytes was biased to an alternatively activated phenotype. Partial depletion of these CD11b 1 mononuclear cells using CD11b-diphtheria toxin (DT) receptor transgenic mice resulted in 60% mortality by 40 hours of hyperoxia exposure with more severe lung injury, perivascular edema, and alveolar hemorrhage compared with DT-treated CD11b-DT receptor-negative controls, which displayed no mortality. These results identify an antiinflammatory population of CD11b 1 mononuclear cells that are protective in hyperoxia-induced neonatal lung injury in mice, and suggest that enhancing their beneficial functions may be a treatment strategy in infants at risk for BPD.Keywords: interstitial macrophage; hyperoxia; lung injury; lung development; macrophage polarization
Clinical RelevanceBronchopulmonary dysplasia (BPD) is a common and prevalent lung disease of premature infants. These infants spend many months in the hospital and can require years of respiratory support. Nearly 70% of the most premature infants will develop BPD. We do not have evidence-based therapies to alter BPD progression. Many factors contribute to BPD, including inflammation and exposure to oxygen. This study investigates the role of murine mononuclear cell populations in neonatal lung injury. These findings identify an alternatively activated monocyte/macrophage population that is critical to the neonatal response to hyperoxia-induced lung injury. These results may inform clinical studies of the role of alternatively activated macrophages in human BPD. These mononuclear cells are plastic and may be important therapeutic targets.Bronchopulmonary dysplasia (BPD) remains a common consequence of lifesaving respiratory support for severely premature infants. First described in 1967(1), BPD comprises clinical, radiographic, and pathologic features seen in premature infants surviving severe respiratory distress syndrome and treated with prolonged mechanical ventilation and supplemental oxygen (2). Pathology specimens from BPD lungs exhibited diffuse airway damage, smooth muscle hypertrophy, severe